Chemistry: molecular biology and microbiology – Micro-organism – tissue cell culture or enzyme using process... – Preparing compound containing saccharide radical
Patent
1996-10-08
1998-07-07
Kemmerer, Elizabeth C.
Chemistry: molecular biology and microbiology
Micro-organism, tissue cell culture or enzyme using process...
Preparing compound containing saccharide radical
435 6, C12P 1934, C12Q 168
Patent
active
057767386
ABSTRACT:
The 3' untranslated region of the human prohibitin gene has been isolated for use in a cancer susceptibility screen and as a therapeutic agent for the treatment of cancer.
REFERENCES:
patent: 5401635 (1995-03-01), Nakamura et al.
Davis S; Watson J C. In vitro activation of the interferon-induced, double-stranded RNA-dependent protein kinase PKR by RNA from the 3' untranslated regions of human alpha-tropomyosin. Proc Natl Acad Sci, USA (1996 Jan. 9) 93 (1) 508-13.
Asamoto, M. and Cohen, S.M., "Prohibitin gene is overexpressed but not mutated in rat bladder carcinomas and cell lines," Cancer Let 83:201-207 (1994).
Black, D. and Solomon, E., "The search for the familial breast/ovarian cancer gene," Trends in Genetics 9:22-26 (1993).
Black, et al., "A somatic cell hybrid map of the long arm of human chromosome 17, containing the familial breast cancer locus (BRCAI)," Am J Hum Genet 52:702-710 (1993).
Castilla, et al., "Mutations in the BRCA1 gene in families with early-onset breast and ovarian cancer," Nature Genetics 8:387-391 (1993).
Cliby, et al., "Absence of prohibitin gene mutations in human epithelial ovarian tumors," Gynecologic Oncology 50:34-37 (1993).
Deisseroth, et al., "Genetic therapy of human neoplastic disease," Proc Am Assoc Cancer Res 36:655-656 (1995).
Gross-Bellard, et al., "Isolation of high-molecular-weight DNA from mammalian cells," Eur J Biochem 36:32-38 (1973).
Holmes D.S. and Quigley, M., "A rapid boiling method for the preparation of bacterial plasmids," Anal Biochem 114:193-197 (1981).
Hongyo, et al., "`Cold SSCP`: a simple, rapid and nonradioactive method for optimized single-strand conformation polymorphism analyses," Nuc Acids Res 21:3637-3642 (1993).
Jupe, et al., "Lack of heterozygosity for prohibitin in breast cancer cell lines," Proc Am Assoc Cancer Res 36:569 (abstract 3390) (1995).
Jupe, et al., "Prohibitin antiproliferative activity and lack of heterozygosity in immortalized cell lines," Exp Cell Res 218:577-580 (1995).
Jupe, et al., "The loss of prohibitin's tumor suppressor activity in breast cancer is associated with mutations in its 3' untranslated region," 48th Annual Symposium on Fundamental Cancer Research. Genetic Mechanisms of Cancer, Abstract C-62, Oct. 17-20, 1995.
Jupe, et al., "Prohibitin and breast cancer susceptibility," 35th Annual Meeting of The American Society for Cell Biology, Abstract 2008, p. 346a, Dec. 13, 1995.
Jupe, et al., "The 3' untranslated region of prohibitin and cellular immortalization," Experimental Cell Res 224:128-135 (1996).
Jupe, et al., "Mutations in the 3' untranslated region (3' UTR) of prohibitin are related to loss of function and are diagnostic for breast cancer," Proc Am Assoc Cancer Res 37:583, Abstract 4000 (1996).
Jupe, et al., "Prohibitin in breast cancer cell lines: loss of antiproliferative activity is linked to 3' untranslated region mutations," Cell Growth & Differentiation 7:871-878 (Jul., 1996).
Liu, et al., "Prohibitin expression during cellular senescence of human diploid fibroblasts,"Biochem Biophys Res Comm 201:409-414 (1994).
Manjeshwar, et al., "Prohibitin as a diagnostic for breast cancer susceptibility and tumor development in stained slides of tissue section," Proc Am Assoc Cancer Res 37:257, Abstract 1751 (1996).
McClung, et al., "Isolation of a cDNA hybrid selects antiproliferative mRNA from rat liver," Biochem Biophys Res Comm 164:1316-1322 (1989).
Nuell, et al., "Prohibitin, an evolutionarily conserved intracellular protein that blocks DNA synthesis in normal fibroblasts and HeLa cells," Mol Cell Biol 11:1372-1381 (1991).
Saiki, et al., "Enzymatic amplification of .beta.-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia," Science 230:1350-1354 (1985).
Sato, et al., "The human prohibitin (PHB) gene family and its somatic mutations in human tumors," Genomics 17:762-764 (1993).
Suggs, et al., "Use of synthetic oligonucleotides as hybridization probes: isolation of cloned cDNA sequences for human .beta..sub.2 -microglobulin," Proc Natl Acad Sci 78:6613-6617 (1981).
Tokino, et al., "Absence of germline prohibitin mutations in early inset breast cancer," International J Oncology 3:769-772 (1993).
White, et al., "Assignment of the human prohibitin gene (PHB) to chromosome 17 and identification of a DNA polymorphism," Genomics 11:228-230 (1991).
Dell'Orco, Sr. Robert Thomas
Jupe Eldon
King Robert
Liu Xiao-Tie
MClung J. Keith
Kemmerer Elizabeth C.
Oklahoma Medical Research Foundation
Romeo David S.
LandOfFree
Method of human prohibitin gene analysis does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of human prohibitin gene analysis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of human prohibitin gene analysis will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1204446